Haemonetics stock performance snapshot after recent weakness Haemonetics (HAE) has drawn investor attention after a period of share price weakness, with the stock down about 9% over the past month and ...

Blood products company Haemonetics (NYSE:HAE). reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales ...

Bank of America Global Healthcare Conference 2026 May 12, 2026 11:00 AM EDTCompany ParticipantsChristopher Simon - ...

Q4 FY26 earnings call recap: revenue/EPS, FY27 guidance, Persona PLUS momentum, IVT inflection, and tariff risks—read now.

Investors in Haemonetics Corporation HAE need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $40.00 Call had some of the highest ...

BOSTON (AP) — BOSTON (AP) — Haemonetics Corp. (HAE) on Thursday reported a loss of $20.1 million in its fiscal fourth quarter. On a per-share basis, the Boston-based company said it had a loss of 44 ...

Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets ...

A Yorkshire health technology company is preparing for international expansion after securing fresh investment to scale its ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Haemonetics , Scholar Rock Holding and Ocugen . Claim 55% Off TipRanks. Unlock hed ...

Medical lens company STAAR Surgical (NASDAQ:STAA) will be reporting results this Wednesday afternoon. Here’s what to expect.

The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.

A UK company whose software provides remote training and support for medics using complex laboratory equipment has set its sights on the Asia-Pacific market after raising £1.6m in new funding. Envoke ...